Corient IA’s Axcelis ACLS Stock Holding History

Corient IA’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$947K	Hold	5,000	–	–	0.87%	28
2026 Q1	$465K	Buy	+5,000	New	+$443K	0.44%	66

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Corient IA's ACLS Position: Q2 2026 in Review

Corient IA held its Axcelis (ACLS) position steady in Q2 2026 at 5,000 shares worth $947K. The position accounts for 0.87% of the portfolio, ranked #28.

Corient IA first reported a position in ACLS in Q1 2026 and has held it in 2 quarters since. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

Corient IA held 5,000 shares of Axcelis worth $947K as of Q2 2026.
Corient IA left its Axcelis share count unchanged in Q2 2026.
Axcelis made up 0.87% of Corient IA's portfolio in Q2 2026, its #28 holding.
Corient IA first reported a position in Axcelis in Q1 2026 and has held it in 2 quarters since.
441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Corient IA's 13F filing for Q2 2026, filed 12 Aug 2026.